Open company graph database — free web & API
Login

Taizhou Riken Sino-Foreign Pharmaceutical Industry Co., Ltd.

泰州日健中外製薬工業有限公司タイズウニッケンチュウガイ製薬工業有限会社AliasChugai Pharma China Co., Ltd.Alias
Ticker
—
Listed market
—
Country
China
Employees (non-consolidated)
187
Related companies
2
§01

Basic information

BASIC
Head office
Unit 5702, HongKong New World Tower, No.300 Central Huai Hai Rd., Huangpu District, Shanghai China
Chief executive
Toshiya Sasai
Employees (non-consolidated)
187 people
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

4
Wholesale medical products as Chinese patent drug, Chemical raw material and preparation, AntibioticConstruction of pharmaceutical production projectsResearch and development of medical technologyTechnology transfer and related consulting services.
§04

Related companies

2 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Chugai Pharma China Co., Ltd.
Group Parent
中外集团
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

12 EVENTS

Launched GRANOCYTE®Sources

Opened representative offices in Beijing and ShanghaiSources

Established a Joint Venture, Shanghai Chugai (Shanghai) Co., Ltd., with the Chinese firmSources

Opened a representative office in GuangzhouSources

Reorganized Shanghai Chugai (Shanghai) Co., Ltd. to Chugai Pharma (Shanghai) Consulting Co., Ltd. (CPC) with 3 branches in Beijing, Shanghai and GuangzhouSources

Established Chugai Pharma China Co., Ltd. (CPCC) in China Medical CitySources

Integrated CPC and CPCC; CPCC as surviving companySources

Established Chugai Pharma Technology Taizhou Co., Ltd. (CPTT) as CPCC subsidiarySources

Obtained the production license for CPTTSources

Started sales & promotion for SIGMART® by CPCCSources

Integrated CPS and CPCC; CPCC as surviving companySources

Started sales & promotion for EDIROL® by CPCCSources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑